Context Therapeutics Inc. (CNTX)

Context Therapeutics Statistics

Total Valuation

CNTX has a market cap or net worth of $207.65 million. The enterprise value is $141.76 million.

Market Cap	207.65M
Enterprise Value	141.76M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

CNTX has 91.88 million shares outstanding. The number of shares has increased by 62.94% in one year.

Current Share Class	91.88M
Shares Outstanding	91.88M
Shares Change (YoY)	+62.94%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	1.36%
Owned by Institutions (%)	24.42%
Float	42.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.43
P/TBV Ratio	3.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.52, with a Debt / Equity ratio of 0.00.

Current Ratio	8.52
Quick Ratio	8.23
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.39% and return on invested capital (ROIC) is -31.80%.

Return on Equity (ROE)	-46.39%
Return on Assets (ROA)	-29.79%
Return on Invested Capital (ROIC)	-31.80%
Return on Capital Employed (ROCE)	-65.65%
Weighted Average Cost of Capital (WACC)	14.30%
Revenue Per Employee	n/a
Profits Per Employee	-$2.41M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +139.48% in the last 52 weeks. The beta is 1.83, so CNTX's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	+139.48%
50-Day Moving Average	2.61
200-Day Moving Average	1.54
Relative Strength Index (RSI)	40.62
Average Volume (20 Days)	855,944

Short Selling Information

The latest short interest is 1.11 million, so 1.20% of the outstanding shares have been sold short.

Short Interest	1.11M
Short Previous Month	1.29M
Short % of Shares Out	1.20%
Short % of Float	2.59%
Short Ratio (days to cover)	1.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-39.70M
Pretax Income	-36.12M
Net Income	-36.12M
EBITDA	-39.69M
EBIT	-39.70M
Earnings Per Share (EPS)	-$0.38

Balance Sheet

The company has $66.00 million in cash and $112,064 in debt, with a net cash position of $65.88 million or $0.72 per share.

Cash & Cash Equivalents	66.00M
Total Debt	112,064
Net Cash	65.88M
Net Cash Per Share	$0.72
Equity (Book Value)	60.47M
Book Value Per Share	0.66
Working Capital	60.33M

Cash Flow

In the last 12 months, operating cash flow was -$26.39 million and capital expenditures -$33,948, giving a free cash flow of -$26.42 million.

Operating Cash Flow	-26.39M
Capital Expenditures	-33,948
Depreciation & Amortization	16,251
Net Borrowing	n/a
Free Cash Flow	-26.42M
FCF Per Share	-$0.29

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.94%
Shareholder Yield	-62.94%
Earnings Yield	-17.40%
FCF Yield	-12.72%

Analyst Forecast

The average price target for CNTX is $6.60, which is 192.04% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.60
Price Target Difference	192.04%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1